ChooMee Inc. – Trademark Portfolio
Entity Type: 03
ChooMee Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 21 (Housewares) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 7 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CHOOMEE and BUON BAMBINI. The owner is based in Rocklin, CA.
2351 Sunset Boulevard, No. 170-773
Rocklin, CA 95765
Showing of trademarks Trademarks
Trademark Classifications
ChooMee Inc.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Advertising; business management; business administration; office functions
Machines and machine tools; motors and engines; machine coupling and transmission components
Frequently Asked Questions
How many trademarks does ChooMee Inc. have?
ChooMee Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 1 cancelled.
What trademark classes does ChooMee Inc. file in?
ChooMee Inc. files trademarks across 7 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 5 (Pharmaceuticals), Class 11 (Environmental Control), Class 8 (Hand Tools), Class 35 (Advertising & Business). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.
What are ChooMee Inc.'s most well-known trademarks?
ChooMee Inc.'s registered trademark portfolio includes well-known marks such as CHOOMEE and BUON BAMBINI. These are among 2 currently registered trademarks in the portfolio.
What is ChooMee Inc.'s trademark registration success rate?
ChooMee Inc. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.